Renal autotransplantation (AuT) was initially described by James Hardy in 1963 for the management of high ureteric injuries. 1 This technique was further successfully described for complex renal vascular reconstruction. 2,3 Since then, there have been various case series and reports describing the use of ex-vivo partial nephrecromy (ExPN) and AuT for dealing with complex renal tumours. [4] [5] [6] The main advantage of this approach is to preserve renal function and prevent the morbidity and poor quality of life associated with renal replacement therapy (RRT).
case of ex-vivo pyeloplasty performed on a patient who had two previously failed pyeloplasties.
Materials and methods

Case 1
A 63-year-old man presented with a spontaneous bleed from a 5.2 cm upper pole renal mass in a solitary right kidney ( Figure 1 ). The patient had a significant medical history of ischaemic heart disease, diabetes, chronic kidney disease stage III and warfarination for pulmonary embolism. Creatinine and estimated glomerular filtration rate (eGFR) at presentation were 124 umol/L and 51 ml/ min/1.73 m 2 , respectively. The patient had selective embolisation performed in an acute setting to control haemorrhage. The initial scans were not conclusive as to whether the mass was renal cell carcinoma (RCC) or haemorrhagic cyst. A follow-up scan 4 months later ( Figure 2 ) suggested that the appearances of mass were consistent with RCC and had shown an increase in size to 6.3 cm.
The case was discussed in the regional multidisciplinary team (MDT) and it was felt at the time that an in-vivo partial nephrectomy would be technically challenging due to the size and high RENAL scoring system of the tumour, and the fact that it bled and needed selective embolisation. This would carry a higher risk of peri-operative complications, namely bleeding, positive margins, and a risk of total nephrectomy, rendering the patient on dialysis. Therefore, an ex-vivo surgery was considered and further opinion was sought from the urology team at Oxford Radcliffe hospitals. The consensus was that in order to achieve maximum cancer control and preserve renal function, the best option would be to proceed with ExPN and AuT. This was extensively discussed with the patient with all possible peri-operative complications. These included the risks described by the BAUS specific laparoscopic nephrectomy consent form. In addition to the risk of cold ischaemia-related decline in renal function, AuT-related complications, namely vascular complications (vascular thrombosis, bleeding) and urinary complications (urine leak from the renorrhaphy and/or reimplantation, ureteric stricture) were discussed.
Case 2
A 50-year-old fit man presented with visible haematuria. Computed tomography (CT) scan confirmed large bilateral renal masses ( Figure 3 ). MDT discussions involved transplant, nephrology and vascular teams. Options were discussed with the patient by the combined urology, transplant and nephrology team, which were: (a) bilateral radical nephrectomies (RNs) followed by RRT and then transplant; (b) bilateral ExPN and AuT with a limited chance of success. The patient and his family opted for the latter option.
Case 3
A 50-year-old man had had a previous right open pyeloplasty for a pelvic-ureteric junction (PUJ) obstruction in 1990 and a re-do robotic pyeloplasty performed in 2012. The patient presented with recurrence of the symptoms with MAG3 suggestive of an obstructive picture and relative function of 39%. Conventional open or laparoscopic pyeloplasty was not deemed appropriate due to a long upper ureteric stricture, which would preclude another dismembered pelvic-ureteric anastomosis. Surgical options were discussed with the patient, which were: (a) open 
Results
All nephrectomies and bench surgeries with bench cold perfusion and subsequent AuT were performed by the urologist (AAT) and the transplant surgeon (TB). No intraoperative complications were observed and there was no need for blood transfusion.
Case 1
Following laparoscopic RN, the specimen was placed in an ice-bath solution and flushed with histidine-tryptophanketogluterate solution. ExPN was performed with adequate resection margin. Reconstruction of the pelvi-calyceal system and a two-layer renorrhaphy was performed. Renal AuT was performed in the ipsilateral pelvis by an extraperitoneal approach through a Gibson's incision, with endto-side anastomosis of the renal vessels to the external iliac artery and vein. Total time for RN was 3 hours, while ExPN and AuT were completed in 2 hours 45 minutes. Postoperatively the patient had a brief period of acute tubular necrosis but did not require RRT. Doppler ultrasound scan had suggested good blood flow ( Figure 4 ) and patient was discharged on the 10th postoperative day. Histology had confirmed grade 3, papillary type 2 pT2a RCC with negative margins. The last scan at 6 months' follow-up showed no evidence of disease recurrence. The renal functions remain stable with a last creatinine of 193 µmol/L and eGFR of 31 ml/min/1.73 m 2 .
Case 2
Bilateral RNs were performed with an open approach with midline laparotomy incision.
Left: ExPN was performed. The tumour was found to be involving the main renal vein and suspicious areas in a peripheral branch. A frozen section of the peripheral vein confirmed involvement hence a decision was made to abandon this kidney.
Right: The main renal vein was also found to be involved. ExPN was performed to salvage about 30% of renal tissue with a branch of the main renal artery and vein available for vascular anastomosis. AuT was performed in the right iliac fossa as described above. After an initial excellent perfusion of the transplanted kidney, it became congested. Intra-operative Doppler demonstrated arterial flow, but sufficient venous flow could not be confirmed. The total time for bilateral RN was 4 hours while the ExPN and AuT for the right kidney was 2 hours 30 minutes. On postoperative day 1 the patient became anuric, developing acute kidney injury needing RRT. Dopplers suggested a very high resistance index of the renal artery, suggesting venous occlusion of the autotransplanted kidney ( Figure 5 ). The patient was taken back to the theatre and on exploration, more than 50% of the kidney remnant was found to be infarcted with the renal vein completely thrombosed. It was decided to remove the kidney, rendering the patient anephric. The histology confirmed grade 2 with focal areas of grade 3, pT3a RCC with clear margin. The histology of the autotransplanted kidney remnant removed during the re-do exploration was free of tumour. The last CT scan performed 8 months postoperatively suggested recurrence in a right 3 cm paracaval lymph node and left adrenal, awaiting a further treatment decision. Genetic testing has confirmed the patient to be von Hippel-Lindau positive.
Case 3
Laparosocopic nephrectomy was found to be challenging due to excessive adhesions, with a total operative time of 3 hours. Ex-vivo reconstruction was performed, first by excising most of the scarred renal pelvis and the upper two-thirds of the ureter, most of which was strictured and devascularised from previous interventions. The remaining healthy edges of the renal pelvis were reconstructed, following the principles of Anderson-Hynes pyeloplasty, and anastomosing it to a healthy spatulated distal third of the ipsilateral ureter (Figures 6 and 7) . After preparing the renal artery and vein, AuT was performed in right iliac fossa (Figure 8 ). The total bench and AuT time was 2 hours. Postoperatively patient developed wound infection treated with antibiotics and was discharged on day 7 postoperatively. After 10 months' follow-up, patient remains completely asymptomatic with stable renal function.
Discussion
Laparoscopic and robotic partial nephrectomy have emerged as the gold standard treatment for small renal masses. 7, 8 This is particularly important in patients with solitary kidney, bilateral tumours or pre-existing renal impairment. However, in complex cases this may become technically more challenging to perform nephron-sparing surgery in vivo. For such cases, ExPN and AuT can achieve better tumour resection in a bloodless field, providing improved oncological outcomes without compromising renal function.
The largest UK series to date from Oxford, 4 describes their experience of eight cases in an abstract form. The authors found that the ExPN was associated with longer operative times but reduced positive surgical margins and offered equivalent oncological outcomes compared to invivo partial nephrectomy. The two groups had no difference in terms of peri-operative complication rates and length of hospital stay. In a case report that offers the longest follow-up for ExPN performed for a 5.5 cm renal tumour infiltrating the collecting system of a single kidney, Karczewski et al. 9 reported the patient to have stable renal functions and remained recurrence free after 8 years' follow-up. This technique has also been used with successful outcomes in treating transitional cell carcinoma of the collecting system in a single functioning unit. 6, 10 The result of our first case in consistency with the published literature has shown an overall good outcome in terms of peri-operative morbidity and cancer clearance, although long-term outcomes need to be assessed.
The proponents of this technique have successfully demonstrated the laparoscopic approach for performing nephrectomy before proceeding with bench surgery and AuT. 5, 6 This has resulted in reduced operative morbidity. In our series, two out of three cases were amenable to the laparoscopic approach for performing nephrectomy, which has shown acceptable operating times and reduced morbidity in terms of hospital stay and time to convalescence. This approach has been traditionally followed for renal malignancy. It has also been utilised for benign conditions such as bilateral giant angiomyolipoma 6 and for renal calculus disease 11 with variable success rates. To our knowledge, our experience of successfully treating recurrent PUJ obstruction after two pyeloplasties is the first reported case of its kind.
Our experience of dealing with the case of bilateral renal tumours with venous involvement provides the biggest learning point, which although performed for imperative reasons, carried a high risk of failure due to the locally advanced nature of the bilateral renal tumours. In addition, the potential use of an augmented venous graft could have prevented the peri-operative venous occlusion and offered preservation of the autotransplanted kidney.
Conclusion
Based on our cases, we conclude that ex-vivo renal surgery and AuT is a viable treatment option for both complex benign and malignant renal pathologies. It helps to preserve renal function, does not compromise oncological outcomes in malignant cases and improves quality of life by avoiding the need for RRT. When possible the laparoscopic approach should be used for performing nephrectomy to reduce the overall morbidity. However, appropriate patient selection is of paramount significance. We also recommend MDT involvement for treating these cases.
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